However, other molecular pathways are implicated in MK AML pathogenesis and rely on a peculiar mutational signature targeting NOTCH1 (rarely reported in AML), BCOR/BCORL1, or RUNX1 genes (25). Here, BCOR is linked to acute myeloid leukemia.